Macugen
FDA warns Gilead over contamination risks at California facility
October 25, 2010Manufacturing and Production AmBisome, Cayston, FDA, Gilead, Macugen, Viread, manufacturing compliance, pharma manufacturing
Gilead Sciences has been sent a warning letter from the FDA after failing to rectify problems at a facility used to …
NICE to re-think blindness drugs decision
August 9, 2007Sales and Marketing AMD, Lucentis, Macugen, NICE
NICE will delay issuing final guidance on two blindness drugs after an unprecedented patient outcry over its decision to block …
NICE set to block blindness drugs
June 15, 2007Sales and Marketing AMD, Lucentis, Macugen, NICE
Most patients in England and Wales will be denied access to drugs for the leading cause of sight loss if …
Latest content
Migraine annual economic and quality-of-life burden in UK
October 1, 2026
bit.bio expands human heart cell portfolio through myriamed partnership
September 30, 2026
Phoenix Labs acquires Kent Pharma
September 29, 2026
Astoriom acquires Sampled’s UK stability storage operations
September 28, 2026
